bayer aspirin tablet
bayer (pty) ltd û isando - tablet - see ingredients - each tablet contains aspirin 300 mg
bayer aspirin cardio 100 tablet
bayer (pty) ltd û isando - tablet - see ingredients - each tablet contains aspirin 100,0 mg
bayer aspirin original flavour tablet
bayer (pty) ltd û isando - tablet - see ingredients - each chew tablet contains aspirin 500,0 mg
bayer aspirin plus c tablet
bayer (pty) ltd û isando - tablet - see ingredients - each effervescent tablet contains aspirin 400,0 mg vitamin c 240,0 mg
bayer aspirin 500 t tablet
bayer (pty) ltd û isando - tablet - see ingredients - each tablet contains aspirin 500,0 mg
bayer aspirin 1000 tablet
bayer (pty) ltd û isando - tablet - see ingredients - each effervescent tablet contains aspirin 500,0 mg
avelox- moxifloxacin hydrochloride tablet, film coated
redpharm drug inc. - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin hydrochloride 400 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of avelox and other antibacterial drugs, avelox should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. avelox tablets and iv are indicated for the treatment of adults (≥ 18 years of age) with infections caused by susceptible strains of the designated microorganisms in the conditions listed below [see dosage and administration (2) and use in specific populations (8.5)]. culture and susceptibility testing appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin
avelox- moxifloxacin hydrochloride tablet, film coated
physicians total care, inc. - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of avelox and other antibacterial drugs, avelox should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. avelox tablets and iv are indicated for the treatment of adults (≥ 18 years of age) with infections caused by susceptible strains of the designated microorganisms in the conditions listed below [see dosage and administration (2) and use in specific populations (8.5)]. culture and susceptibility testing appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin
kogenate bayer
bayer ag - octocog alfa - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor-viii deficiency).this preparation does not contain von willebrand factor and is therefore not indicated in von willebrand's disease.
a and d- dimethicone and zinc oxide cream
bayer healthcare llc. - dimethicone (unii: 92ru3n3y1o) (dimethicone - unii:92ru3n3y1o), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - dimethicone 11.09 mg in 1 g - - helps treat and prevent diaper rash - protects minor skin irritation due to diaper rash and helps seal out wetness